Additional file 1: Figure S1. of Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner
NIH| Flow Cytometry Core: Core 2 ,
NIH| The new biology of estrogen action in aromatase resistance breast cancer cells
Authors: Ogony, Joshua; Choi, Hye; Asona Lui; Cristofanilli, Massimo; Lewis-Wambi, Joan;
Additional file 1: Figure S1. of Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner
Abstract
Effects of IFITM1 knockdown on cell cycle and cell-cycle proteins in SUM149 cells. (PPT 212 kb)
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
citations
Citations provided by BIP!
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
popularity
Popularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
0
Average
Average
Average
Green
Funded by
Related to Research communities
Cancer Research
